Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas

Cancer

Volumn 119, Issue 24, 2013, Pages 4249-4258

  Hwang, Sungjae ^a   Mahadevan, Swarna ^a   Qadir, Fatima ^a   Hutchison, Iain L ^b   Costea, Daniela Elena ^c   Neppelberg, Evelyn ^d   Liavaag, Per Gunnar ^d   Waseem, Ahmad ^a   Teh, Muy Teck ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c UNIVERSITY OF BERGEN   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

biomarkers; biopsy; cancer epigenetics; diagnostic; epigenome; FOXM1; methylome; promoter methylation; reprogramming; squamous cell carcinoma; tissue

Indexed keywords

ADULT; ARTICLE; C6ORF136 GENE; CHPF GENE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; FLNA GENE; FOXM1 GENE; GENE EXPRESSION; GENE INDUCTION; GENETIC MARKER; GINGIVA TUMOR; GLT8D1 GENE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MGAT1 GENE; MIDDLE AGED; MOUTH SQUAMOUS CELL CARCINOMA; NDUFA10 GENE; NORWAY; ONCOGENE; PAFAH1B3 GENE; PRIORITY JOURNAL; PROMOTER REGION; SPCS1 GENE; TONGUE CARCINOMA; UNITED KINGDOM; UPREGULATION;

BIOMARKERS; BIOPSY; CANCER EPIGENETICS; DIAGNOSTIC; EPIGENOME; FOXM1; METHYLOME; PROMOTER METHYLATION; REPROGRAMMING; SQUAMOUS CELL CARCINOMA; TISSUE;

CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GREAT BRITAIN; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NORWAY; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84889887447     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28354     Document Type: Article

References (30)

1. Tsai HC, Baylin SB,. Cancer epigenetics: linking basic biology to clinical medicine. Cell Res. 2011; 21: 502-517.
2. Baylin SB, Jones PA,. A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer. 2011; 11: 726-734.
3. Yamada Y, Watanabe A,. Epigenetic codes in stem cells and cancer stem cells. Adv Genet. 2010; 70: 177-199.
4. Teh MT, Gemenetzidis E, Patel D, et al. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma. PLoS One. 2012; 7: e34329.
5. Gemenetzidis E, Bose A, Riaz AM, et al. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS One. 2009; 4: e4849.
6. Waseem A, Ali M, Odell EW, Fortune F, Teh MT,. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma. Oral Oncol. 2010; 46: 536-542.
7. Myatt SS, Lam EW,. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 2007; 7: 847-859.
8. Teh MT,. Initiation of human tumourigenesis: upregulation of FOXM1 transcription factor. In:, Hayat MA, ed. Stem Cells and Cancer Stem Cells. Volume 3. The Netherlands: Springer; 2012: 149-154.
9. Gemenetzidis E, Costea DE, Parkinson EK, Waseem A, Wan H, Teh MT,. Induction of human epithelial stem/progenitor expansion by FOXM1. Cancer Res. 2010; 70: 9515-9526.
10. Koo CY, Muir KW, Lam EW,. FOXM1: From cancer initiation to progression and treatment. Biochim Biophys Acta. 2012; 1819: 28-37.
11. Teh MT, Hutchison IL, Costea DE, et al. Exploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosis. Int J Cancer. 2013; 132: 2095-2106.
12. Teh MT, Gemenetzidis E, Chaplin T, Young BD, Philpott MP,. Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes. Mol Cancer. 2010; 9: 45.
13. Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55: 611-622.
14. Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000; 60: 5954-5958.
15. Georgiou E, Valeri R, Tzimagiorgis G, et al. Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: correlation with smoking. Eur J Cancer Prev. 2007; 16: 396-402.
16. Li LC, Dahiya R,. MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002; 18: 1427-1431.
17. Scully C, Bagan JV, Hopper C, Epstein JB,. Oral cancer: current and future diagnostic techniques. Am J Dent. 2008; 21: 199-209.
18. Woolgar JA, Triantafyllou A,. Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis. Oral Oncol. 2009; 45: 361-385.
19. Flanagan LA, Chou J, Falet H, Neujahr R, Hartwig JH, Stossel TP,. Filamin A, the Arp2/3 complex, and the morphology and function of cortical actin filaments in human melanoma cells. J Cell Biol. 2001; 155: 511-517.
20. Vadlamudi RK, Li F, Adam L, et al. Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1. Nat Cell Biol. 2002; 4: 681-690.
21. Li C, Yu S, Nakamura F, et al. Pro-prion binds filamin A, facilitating its interaction with integrin beta1, and contributes to melanomagenesis. J Biol Chem. 2010; 285: 30328-30339.
22. Wang Y, Kreisberg JI, Bedolla RG, Mikhailova M, deVere White RW, Ghosh PM,. A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells. Oncogene. 2007; 26: 6061-6070.
23. Bedolla RG, Wang Y, Asuncion A, et al. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res. 2009; 15: 788-796.
24. Castoria G, D'Amato L, Ciociola A, et al. Androgen-induced cell migration:role of androgen receptor/filamin A association. PLoS One. 2011; 6: e17218.
25. Uramoto H, Akyurek LM, Hanagiri T,. A positive relationship between filamin and VEGF in patients with lung cancer. Anticancer Res. 2010; 30: 3939-2944.
26. Zhong Z, Yeow WS, Zou C, et al. Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells. Cancer Res. 2010; 70: 2105-2114.
27. Burton ER, Gaffar A, Lee SJ, et al. Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer. Mol Cancer Res. 2011; 9: 1126-1138.
28. Ai J, Huang H, Lv X, et al. FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma. Cell Physiol Biochem. 2011; 27) 207-216.
29. Kitagawa H, Izumikawa T, Uyama T, Sugahara K,. Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization. J Biol Chem. 2003; 278: 23666-23671.
30. Kalathas D, Theocharis DA, Bounias D, et al. Chondroitin synthases I, II, III and chondroitin sulfate glucuronyltransferase expression in colorectal cancer. Mol Med Rep. 2011; 4: 363-368.